ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,297Medicare Part D Prescriptions Filled, Including Refills

Rank: 293 out of 2888

$1.38M Total Retail Price of All Prescriptions

Rank: 87 out of 2888

672 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

40% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 950 778 S3 1 4
LISINOPRIL 648 587 2 3
SIMVASTATIN 615 542 3 2
AMLODIPINE BESYLATE 537 470 4 5
ALENDRONATE SODIUM 503 448 5 23
LEVOTHYROXINE SODIUM 490 434 6 1
OMEPRAZOLE 429 374 7 7
HYDROCHLOROTHIAZIDE 365 334 8 15
METFORMIN HCL 317 269 9 8
METFORMIN HCL ER 278 231 10 53
PRAVASTATIN SODIUM 277 229 11 12
ACTOS 244 221 12 108
ATENOLOL 207 181 13 25
JANUVIA 194 165 14 48
LOSARTAN POTASSIUM 187 164 15 18
GABAPENTIN 177 147 16 13
FUROSEMIDE 173 142 17 6
CARVEDILOL 159 146 18 21
MELOXICAM 152 128 19 31
TAMSULOSIN HCL 146 131 20 29
METOPROLOL TARTRATE 143 116 21 10
ZOLPIDEM TARTRATE 141 117 22 17
HYDRALAZINE HCL 141 123 22 59
DOXYCYCLINE HYCLATE 138 119 24 123
CITALOPRAM HBR 137 121 25 24
PIOGLITAZONE HCL 130 110 R 26 248
LOSARTAN-HYDROCHLOROTHIAZIDE 127 117 27 46
BYDUREON 119 87 28 468
JANUMET 111 95 29 131
RANITIDINE HCL 110 97 30 56
NEXIUM 109 85 31 19
ZETIA 106 97 32 81
NAMENDA 104 103 33 34
METOPROLOL SUCCINATE 103 88 34 11
DIPYRIDAMOLE 95 70 R 35 378
POTASSIUM CHLORIDE 93 84 36 14
PEN NEEDLE 91 77 37 110
TRAMADOL HCL-ACETAMINOPHEN 88 78 38 95
EVISTA 82 74 39 125
FINASTERIDE 81 80 40 102
FLUTICASONE PROPIONATE 77 59 41 32
BENICAR 72 72 42 138
TRIAMCINOLONE ACETONIDE 71 66 43 145
BYETTA 70 69 44 322
MECLIZINE HCL 68 55 45 122
ATORVASTATIN CALCIUM 68 56 45 9
WARFARIN SODIUM 68 58 45 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 57 48 88
CYMBALTA 64 57 49 44
SINGULAIR 63 54 50 85
GENERLAC 52 50 51 318
VYTORIN 52 40 51 155
CYCLOBENZAPRINE HCL 50 30 R 53 68
CELEBREX 50 44 53 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.